– Health Innovation II. –

– Health Innovation II. –

Virtual Conference Sessions of The Vice-Consulate of Hungary in Houston

Overview:

Biannually, a new cohort of health care startups from around the world join the TMCx program to start, build, and sustain their commercialization pathway. 

Each company experiences a customized journey as they are embedded into a community of top-tier hospitals and seasoned advisors. 

At TMCx, each startup will prepare their product for clinical validation, funding, and deployment into the world's largest medical marketplace - the Texas Medical Center.

TMCx's Innovation strategists champion every medical device or digital health company's success through strategic introductions across the world's largest medical complex. 

Embedded industry partners to academic partners provide world-class research, prototypes, and pathways to market. Startups that experience TMCx expects success.

This year the Hungarian SOTE Innovation Center will council Hungarian innovators to participate in the Texan program too.

Agenda:

Wednesday, January 20, 2021

09:00 a.m. Central Standard Time (CST), Texas

04:00 p.m. Central European Time (CET), Hungary

One day prior to the start of the Virtual Conference all registered attendees will receive an email which includes important details, updates, and LINK TO JOIN.

Detailed agenda (US CST):

09:00 – 09:05 Welcome remarks by Gábor Markocsány, Consul

09:05 – 09:25  Presentation of TMC Innovation and International Programs – Samantha Nava

09:25 – 09:45  Presentation of the SOTE Innovation Center - Gabriella Sódar

09:45 – 10:00  Interactive discussion - Q&A

Details:

Samantha Nava, PhD is an Innovation Strategist at TMC Innovation, where she supports innovation initiatives for member institutions in the Texas Medical Center. Dr Nava assess hospital needs and recruits startup companies worldwide to participate in the TMCx accelerator program. During the program, Dr Nava engages TMCx companies to refine business models, value proposition, competitive landscape, market entry and other strategic needs. She also conducts due diligence for the TMC Venture Fund to determine fit within the fund's mission and goals. In addition, she also directs TMCx-alpha to support local innovation at its earliest stages; from physician and investigator-initiated ventures.

Gabriella Sódar is the Head of Technology Transfer at Semmelweis University, a leading institution of higher education in Hungary within the area of medicine and health sciences, and the largest provider of health care services in Hungary.  At Semmelweis Innovation Center Ms. Sódar deals with the country’s most advanced medical technologies thanks to the exceptional researcher human capacity of the University. The Center arranges all intellectual property management issues from protection to utilization, developing business, operating a Semmelweis Scientific and Innovation Fund, a Proof of concept fund. Ms. Sódar also coordinates all knowledge transfer processes connected to innovation at the University.

Partners:

The Vice-Consulate of Hungary in Houston

HACCTX - Hungarian-American Chamber of Commerce, Texas

INPUT Program